**Definition**
___
Endometrial glands and stroma infiltration of the myometrium.

**Epidemiology**
___
prevalence varies: 8 - 50%
Higher prevalence among infertile women
commonly diagnosed in women aged 35â€“50


**Pathophysiology**
___
- Endometrial tissue invades myometrium
- Junctional zone disruption
- Uterine hyperplasia and inflammation

**Different theories exist
___
- Endometrial-Myometrial interface microtrauma
- Endometrium enhanced invasion of the myometrium
- Myometrial stem cell metaplasia
- Retrograde menstrual effluent (endometrial cell) infiltrate uterine wall
- Abnormal uterine development in response to epigenetic and genetic modifications

**Clinical feature**
___
- Chronic pelvic pain
- Heavy menstrual bleeding (menorrhagia)
- Dysmenorrhoea
- Enlarged, tender uterus

**Complications**
___
- Infertility
- Miscarriages
- IUGR
- Preeclampsia

**Investigation**
___
- Histology
- Transvaginal ultrasound
- MRI 
- Laparoscopy

**Imaging features**
___
- MUSA
	- Junctional zone disruption: echogenic subendometrial line  in continuum with the endometrium
	- Myometrial cyst
	-  Hyperechoic island within the myometrium


**Treatment**
___
- **Medical therapy
	- NSAIDs for pain
- **Hormonal therapies 
	- progestogens
		- LNG-IUS  for menorrhagia and dysmenorrhea 
		- Selective synthetic oral progestin (SSOP: Dienogest ) for dysmenorhea and dysperunia
		- Selective progesterone receptor modulators(SPRMs: Ulipristal acetate, Mifepristone) for halting endometrial bleeding and reducing uterine size
	- GnRH analogs for dysmenorrhea and menorrhagia
- **Enzyme
	- Aromatase inhibitor: Reduces uterine volume in combination with GnRH
- **Radiological 
	- Uterine artery embolization (UAE)
	- Ablative procedures (Radiofrequency ablation RFA)
	- Magnetic resonance guided focus ultrasound surgery (MR-FUS)
- **Surgery
	- Hysterectomy (definitive treatment)
	- Surgical conservative therapy

